{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:21:12Z","timestamp":1793578872040,"version":"4.5.0"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Aging"],"DOI":"10.1038\/s41514-024-00170-4","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T07:03:10Z","timestamp":1729494190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Cell senescence in cardiometabolic diseases"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1163-7499","authenticated-orcid":false,"given":"Mandy O. J.","family":"Grootaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"170_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/febs.15570","volume":"288","author":"E Gonzalez-Gualda","year":"2021","unstructured":"Gonzalez-Gualda, E., Baker, A. G., Fruk, L. & Munoz-Espin, D. A guide to assessing cellular senescence in vitro and in vivo. FEBS J. 288, 56\u201380, https:\/\/doi.org\/10.1111\/febs.15570 (2021).","journal-title":"FEBS J."},{"key":"170_CR2","doi-asserted-by":"publisher","unstructured":"Wang, B., Han, J., Elisseeff, J. H. & Demaria, M. The senescence-associated secretory phenotype and its physiological and pathological implications. Nat. Rev. Mol. Cell Biol. https:\/\/doi.org\/10.1038\/s41580-024-00727-x (2024).","DOI":"10.1038\/s41580-024-00727-x"},{"key":"170_CR3","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810234","volume":"11","author":"M Paez-Ribes","year":"2019","unstructured":"Paez-Ribes, M., Gonzalez-Gualda, E., Doherty, G. J. & Munoz-Espin, D. Targeting senescent cells in translational medicine. EMBO Mol. Med. 11, e10234, https:\/\/doi.org\/10.15252\/emmm.201810234 (2019).","journal-title":"EMBO Mol. Med."},{"key":"170_CR4","doi-asserted-by":"publisher","unstructured":"Paramos-de-Carvalho, D., Jacinto, A. & Saude, L. The right time for senescence. Elife 10 https:\/\/doi.org\/10.7554\/eLife.72449 (2021).","DOI":"10.7554\/eLife.72449"},{"key":"170_CR5","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363\u20139367, https:\/\/doi.org\/10.1073\/pnas.92.20.9363 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"170_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1083\/jcb.201708092","volume":"217","author":"D McHugh","year":"2018","unstructured":"McHugh, D. & Gil, J. Senescence and aging: causes, consequences, and therapeutic avenues. J. Cell Biol. 217, 65\u201377, https:\/\/doi.org\/10.1083\/jcb.201708092 (2018).","journal-title":"J. Cell Biol."},{"key":"170_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/cvr\/cvs352","volume":"97","author":"A Cardus","year":"2013","unstructured":"Cardus, A., Uryga, A. K., Walters, G. & Erusalimsky, J. D. SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence. Cardiovasc. Res. 97, 571\u2013579, https:\/\/doi.org\/10.1093\/cvr\/cvs352 (2013).","journal-title":"Cardiovasc. Res."},{"key":"170_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/CIRCRESAHA.120.318353","volume":"128","author":"MOJ Grootaert","year":"2021","unstructured":"Grootaert, M. O. J., Finigan, A., Figg, N. L., Uryga, A. K. & Bennett, M. R. SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis. Circ. Res. 128, 474\u2013491, https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.318353 (2021).","journal-title":"Circ. Res."},{"key":"170_CR9","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.18632\/aging.101268","volume":"9","author":"BM Hall","year":"2017","unstructured":"Hall, B. M. et al. p16(Ink4a) and senescence-associated beta-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli. Aging 9, 1867\u20131884, https:\/\/doi.org\/10.18632\/aging.101268 (2017).","journal-title":"Aging"},{"key":"170_CR10","doi-asserted-by":"publisher","unstructured":"Garrido, A. M. et al. Efficacy and limitations of senolysis in atherosclerosis. Cardiovasc. Res. https:\/\/doi.org\/10.1093\/cvr\/cvab208 (2021).","DOI":"10.1093\/cvr\/cvab208"},{"key":"170_CR11","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1080\/15548627.2015.1096485","volume":"11","author":"MO Grootaert","year":"2015","unstructured":"Grootaert, M. O. et al. Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis. Autophagy 11, 2014\u20132032, https:\/\/doi.org\/10.1080\/15548627.2015.1096485 (2015).","journal-title":"Autophagy"},{"key":"170_CR12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1126\/science.aaf6659","volume":"354","author":"BG Childs","year":"2016","unstructured":"Childs, B. G. et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science 354, 472\u2013477, https:\/\/doi.org\/10.1126\/science.aaf6659 (2016).","journal-title":"Science"},{"key":"170_CR13","doi-asserted-by":"publisher","unstructured":"Silva, E. Pharmacological clearance of senescent cells reverses HFpEF hallmarks by decreasing inflammation, endothelial dysfunction and cardiac fibrosis. Preprint at https:\/\/doi.org\/10.21203\/rs.3.rs-624229\/v1 (2021).","DOI":"10.21203\/rs.3.rs-624229\/v1"},{"key":"170_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1083\/jcb.201009094","volume":"192","author":"F Rodier","year":"2011","unstructured":"Rodier, F. & Campisi, J. Four faces of cellular senescence. J. Cell Biol. 192, 547\u2013556, https:\/\/doi.org\/10.1083\/jcb.201009094 (2011).","journal-title":"J. Cell Biol."},{"key":"170_CR15","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/ATVBAHA.115.305896","volume":"35","author":"SE Gardner","year":"2015","unstructured":"Gardner, S. E., Humphry, M., Bennett, M. R. & Clarke, M. C. Senescent vascular smooth muscle cells drive inflammation through an interleukin-1alpha-dependent senescence-associated secretory phenotype. Arterioscler. Thromb. Vasc. Biol. 35, 1963\u20131974, https:\/\/doi.org\/10.1161\/ATVBAHA.115.305896 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"170_CR16","doi-asserted-by":"publisher","unstructured":"Takasugi, M. Emerging roles of extracellular vesicles in cellular senescence and aging. Aging Cell 17 https:\/\/doi.org\/10.1111\/acel.12734 (2018).","DOI":"10.1111\/acel.12734"},{"key":"170_CR17","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ncb2784","volume":"15","author":"JC Acosta","year":"2013","unstructured":"Acosta, J. C. et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15, 978\u2013990, https:\/\/doi.org\/10.1038\/ncb2784 (2013).","journal-title":"Nat. Cell Biol."},{"key":"170_CR18","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s43587-021-00121-8","volume":"1","author":"NS Gasek","year":"2021","unstructured":"Gasek, N. S., Kuchel, G. A., Kirkland, J. L. & Xu, M. Strategies for targeting senescent cells in human disease. Nat. Aging 1, 870\u2013879, https:\/\/doi.org\/10.1038\/s43587-021-00121-8 (2021).","journal-title":"Nat. Aging"},{"key":"170_CR19","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1016\/j.celrep.2019.05.095","volume":"27","author":"M Borghesan","year":"2019","unstructured":"Borghesan, M. et al. Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein IFITM3. Cell Rep. 27, 3956\u20133971 e3956, https:\/\/doi.org\/10.1016\/j.celrep.2019.05.095 (2019).","journal-title":"Cell Rep."},{"key":"170_CR20","doi-asserted-by":"publisher","first-page":"e3000599","DOI":"10.1371\/journal.pbio.3000599","volume":"18","author":"N Basisty","year":"2020","unstructured":"Basisty, N. et al. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 18, e3000599, https:\/\/doi.org\/10.1371\/journal.pbio.3000599 (2020).","journal-title":"PLoS Biol."},{"issue":"Suppl 1","key":"170_CR21","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi, C. & Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A Biol. Sci. Med. Sci. 69(Suppl 1), S4\u2013S9, https:\/\/doi.org\/10.1093\/gerona\/glu057 (2014).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"170_CR22","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.jacc.2016.02.047","volume":"67","author":"K Meyer","year":"2016","unstructured":"Meyer, K., Hodwin, B., Ramanujam, D., Engelhardt, S. & Sarikas, A. Essential role for premature senescence of myofibroblasts in myocardial fibrosis. J. Am. Coll. Cardiol. 67, 2018\u20132028, https:\/\/doi.org\/10.1016\/j.jacc.2016.02.047 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"170_CR23","doi-asserted-by":"publisher","first-page":"e74535","DOI":"10.1371\/journal.pone.0074535","volume":"8","author":"F Zhu","year":"2013","unstructured":"Zhu, F. et al. Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction. PLoS ONE 8, e74535, https:\/\/doi.org\/10.1371\/journal.pone.0074535 (2013).","journal-title":"PLoS ONE"},{"key":"170_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10557-020-07075-w","volume":"36","author":"E Dookun","year":"2022","unstructured":"Dookun, E., Passos, J. F., Arthur, H. M. & Richardson, G. D. Therapeutic potential of senolytics in cardiovascular disease. Cardiovasc. Drugs Ther. 36, 187\u2013196, https:\/\/doi.org\/10.1007\/s10557-020-07075-w (2022).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"170_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.arr.2018.02.001","volume":"43","author":"DGA Burton","year":"2018","unstructured":"Burton, D. G. A. & Stolzing, A. Cellular senescence: Immunosurveillance and future immunotherapy. Ageing Res. Rev. 43, 17\u201325, https:\/\/doi.org\/10.1016\/j.arr.2018.02.001 (2018).","journal-title":"Ageing Res. Rev."},{"key":"170_CR26","doi-asserted-by":"publisher","unstructured":"Schloesser, D. et al. Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT\/L axis. J. Cell Biol. 222 https:\/\/doi.org\/10.1083\/jcb.202207097 (2023).","DOI":"10.1083\/jcb.202207097"},{"key":"170_CR27","doi-asserted-by":"publisher","unstructured":"Munoz, D. P. et al. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging. JCI Insight 5 https:\/\/doi.org\/10.1172\/jci.insight.124716 (2019).","DOI":"10.1172\/jci.insight.124716"},{"key":"170_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10335-5","volume":"10","author":"BI Pereira","year":"2019","unstructured":"Pereira, B. I. et al. Senescent cells evade immune clearance via HLA-E-mediated NK and CD8(+) T cell inhibition. Nat. Commun. 10, 2387, https:\/\/doi.org\/10.1038\/s41467-019-10335-5 (2019).","journal-title":"Nat. Commun."},{"key":"170_CR29","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s42255-021-00483-8","volume":"3","author":"CD Wiley","year":"2021","unstructured":"Wiley, C. D. & Campisi, J. The metabolic roots of senescence: mechanisms and opportunities for intervention. Nat. Metab. 3, 1290\u20131301, https:\/\/doi.org\/10.1038\/s42255-021-00483-8 (2021).","journal-title":"Nat. Metab."},{"key":"170_CR30","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/BF01128816","volume":"4","author":"AH Bittles","year":"1984","unstructured":"Bittles, A. H. & Harper, N. Increased glycolysis in ageing cultured human diploid fibroblasts. Biosci. Rep. 4, 751\u2013756, https:\/\/doi.org\/10.1007\/BF01128816 (1984).","journal-title":"Biosci. Rep."},{"key":"170_CR31","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1021\/pr501221g","volume":"14","author":"EL James","year":"2015","unstructured":"James, E. L. et al. Senescent human fibroblasts show increased glycolysis and redox homeostasis with extracellular metabolomes that overlap with those of irreparable DNA damage, aging, and disease. J. Proteome Res. 14, 1854\u20131871, https:\/\/doi.org\/10.1021\/pr501221g (2015).","journal-title":"J. Proteome Res."},{"key":"170_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.stemcr.2019.12.012","volume":"14","author":"E Fernandez-Rebollo","year":"2020","unstructured":"Fernandez-Rebollo, E. et al. Senescence-associated metabolomic phenotype in primary and iPSC-derived mesenchymal stromal cells. Stem Cell Rep. 14, 201\u2013209, https:\/\/doi.org\/10.1016\/j.stemcr.2019.12.012 (2020).","journal-title":"Stem Cell Rep."},{"key":"170_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20030816","volume":"376","author":"W Zwerschke","year":"2003","unstructured":"Zwerschke, W. et al. Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence. Biochem. J. 376, 403\u2013411, https:\/\/doi.org\/10.1042\/BJ20030816 (2003).","journal-title":"Biochem. J."},{"key":"170_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cmet.2015.11.011","volume":"23","author":"CD Wiley","year":"2016","unstructured":"Wiley, C. D. et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 23, 303\u2013314, https:\/\/doi.org\/10.1016\/j.cmet.2015.11.011 (2016).","journal-title":"Cell Metab."},{"key":"170_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251\u2013262, https:\/\/doi.org\/10.1038\/nrm3311 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"170_CR36","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4161\/cc.19800","volume":"11","author":"C Quijano","year":"2012","unstructured":"Quijano, C. et al. Oncogene-induced senescence results in marked metabolic and bioenergetic alterations. Cell Cycle 11, 1383\u20131392, https:\/\/doi.org\/10.4161\/cc.19800 (2012).","journal-title":"Cell Cycle"},{"key":"170_CR37","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.18632\/aging.101126","volume":"8","author":"MA Baraibar","year":"2016","unstructured":"Baraibar, M. A. et al. Impaired energy metabolism of senescent muscle satellite cells is associated with oxidative modifications of glycolytic enzymes. Aging 8, 3375\u20133389, https:\/\/doi.org\/10.18632\/aging.101126 (2016).","journal-title":"Aging"},{"key":"170_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1550-0","volume":"10","author":"J Fafian-Labora","year":"2019","unstructured":"Fafian-Labora, J. et al. FASN activity is important for the initial stages of the induction of senescence. Cell Death Dis. 10, 318, https:\/\/doi.org\/10.1038\/s41419-019-1550-0 (2019).","journal-title":"Cell Death Dis."},{"key":"170_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/cddiscovery.2017.75","volume":"3","author":"AC Flor","year":"2017","unstructured":"Flor, A. C., Wolfgeher, D., Wu, D. & Kron, S. J. A signature of enhanced lipid metabolism, lipid peroxidation and aldehyde stress in therapy-induced senescence. Cell Death Discov. 3, 17075, https:\/\/doi.org\/10.1038\/cddiscovery.2017.75 (2017).","journal-title":"Cell Death Discov."},{"key":"170_CR40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/15216540500091890","volume":"57","author":"R Colavitti","year":"2005","unstructured":"Colavitti, R. & Finkel, T. Reactive oxygen species as mediators of cellular senescence. IUBMB Life 57, 277\u2013281, https:\/\/doi.org\/10.1080\/15216540500091890 (2005).","journal-title":"IUBMB Life"},{"key":"170_CR41","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1093\/nar\/gkm681","volume":"35","author":"JH Chen","year":"2007","unstructured":"Chen, J. H., Hales, C. N. & Ozanne, S. E. DNA damage, cellular senescence and organismal ageing: causal or correlative? Nucleic Acids Res. 35, 7417\u20137428, https:\/\/doi.org\/10.1093\/nar\/gkm681 (2007).","journal-title":"Nucleic Acids Res."},{"key":"170_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/01.RES.0000233315.38086.bc","volume":"99","author":"C Matthews","year":"2006","unstructured":"Matthews, C. et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ. Res. 99, 156\u2013164, https:\/\/doi.org\/10.1161\/01.RES.0000233315.38086.bc (2006).","journal-title":"Circ. Res."},{"key":"170_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1474-9728.2003.00040.x","volume":"2","author":"G Saretzki","year":"2003","unstructured":"Saretzki, G., Murphy, M. P. & von Zglinicki, T. MitoQ counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress. Aging Cell 2, 141\u2013143, https:\/\/doi.org\/10.1046\/j.1474-9728.2003.00040.x (2003).","journal-title":"Aging Cell"},{"key":"170_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.18632\/aging.100423","volume":"4","author":"MC Velarde","year":"2012","unstructured":"Velarde, M. C., Flynn, J. M., Day, N. U., Melov, S. & Campisi, J. Mitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the skin. Aging 4, 3\u201312, https:\/\/doi.org\/10.18632\/aging.100423 (2012).","journal-title":"Aging"},{"key":"170_CR45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.redox.2016.10.014","volume":"11","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. A new role for oxidative stress in aging: the accelerated aging phenotype in Sod1\u2212\/\u2212 mice is correlated to increased cellular senescence. Redox Biol. 11, 30\u201337, https:\/\/doi.org\/10.1016\/j.redox.2016.10.014 (2017).","journal-title":"Redox Biol."},{"key":"170_CR46","doi-asserted-by":"publisher","unstructured":"Mdaki, K. S. & Shi, J. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to cellular senescence. FASEB J. 32 https:\/\/doi.org\/10.1096\/fasebj.2018.32.1_supplement.618.21 (2018).","DOI":"10.1096\/fasebj.2018.32.1_supplement.618.21"},{"key":"170_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/acel.12287","volume":"14","author":"DV Ziegler","year":"2015","unstructured":"Ziegler, D. V., Wiley, C. D. & Velarde, M. C. Mitochondrial effectors of cellular senescence: beyond the free radical theory of aging. Aging Cell 14, 1\u20137, https:\/\/doi.org\/10.1111\/acel.12287 (2015).","journal-title":"Aging Cell"},{"key":"170_CR48","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1042\/BJ20090666","volume":"423","author":"B Lener","year":"2009","unstructured":"Lener, B. et al. The NADPH oxidase Nox4 restricts the replicative lifespan of human endothelial cells. Biochem. J. 423, 363\u2013374, https:\/\/doi.org\/10.1042\/BJ20090666 (2009).","journal-title":"Biochem. J."},{"key":"170_CR49","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/onc.2011.327","volume":"31","author":"U Weyemi","year":"2012","unstructured":"Weyemi, U. et al. ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene 31, 1117\u20131129, https:\/\/doi.org\/10.1038\/onc.2011.327 (2012).","journal-title":"Oncogene"},{"key":"170_CR50","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/msb.2010.5","volume":"6","author":"JF Passos","year":"2010","unstructured":"Passos, J. F. et al. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol. Syst. Biol. 6, 347, https:\/\/doi.org\/10.1038\/msb.2010.5 (2010).","journal-title":"Mol. Syst. Biol."},{"key":"170_CR51","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1474-9726.2012.00795.x","volume":"11","author":"G Nelson","year":"2012","unstructured":"Nelson, G. et al. A senescent cell bystander effect: senescence-induced senescence. Aging Cell 11, 345\u2013349, https:\/\/doi.org\/10.1111\/j.1474-9726.2012.00795.x (2012).","journal-title":"Aging Cell"},{"key":"170_CR52","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019101982","volume":"38","author":"S Victorelli","year":"2019","unstructured":"Victorelli, S. et al. Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction. EMBO J. 38, e101982, https:\/\/doi.org\/10.15252\/embj.2019101982 (2019).","journal-title":"EMBO J."},{"key":"170_CR53","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.bbabio.2015.05.017","volume":"1847","author":"C Correia-Melo","year":"2015","unstructured":"Correia-Melo, C. & Passos, J. F. Mitochondria: are they causal players in cellular senescence? Biochim. Biophys. Acta 1847, 1373\u20131379, https:\/\/doi.org\/10.1016\/j.bbabio.2015.05.017 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"170_CR54","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/febs.16361","volume":"290","author":"H Martini","year":"2023","unstructured":"Martini, H. & Passos, J. F. Cellular senescence: all roads lead to mitochondria. FEBS J. 290, 1186\u20131202, https:\/\/doi.org\/10.1111\/febs.16361 (2023).","journal-title":"FEBS J."},{"key":"170_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ebiom.2017.03.020","volume":"21","author":"VI Korolchuk","year":"2017","unstructured":"Korolchuk, V. I., Miwa, S., Carroll, B. & von Zglinicki, T. Mitochondria in cell senescence: is mitophagy the weakest link? EBioMedicine 21, 7\u201313, https:\/\/doi.org\/10.1016\/j.ebiom.2017.03.020 (2017).","journal-title":"EBioMedicine"},{"key":"170_CR56","doi-asserted-by":"publisher","first-page":"724","DOI":"10.15252\/embj.201592862","volume":"35","author":"C Correia-Melo","year":"2016","unstructured":"Correia-Melo, C. et al. Mitochondria are required for pro-ageing features of the senescent phenotype. EMBO J. 35, 724\u2013742, https:\/\/doi.org\/10.15252\/embj.201592862 (2016).","journal-title":"EMBO J."},{"key":"170_CR57","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41392-023-01378-8","volume":"8","author":"S Xie","year":"2023","unstructured":"Xie, S., Xu, S. C., Deng, W. & Tang, Q. Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications. Signal Transduct. Target. Ther. 8, 114, https:\/\/doi.org\/10.1038\/s41392-023-01378-8 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"170_CR58","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCRESAHA.111.246140","volume":"110","author":"DF Dai","year":"2012","unstructured":"Dai, D. F., Rabinovitch, P. S. & Ungvari, Z. Mitochondria and cardiovascular aging. Circ. Res. 110, 1109\u20131124, https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.246140 (2012).","journal-title":"Circ. Res."},{"key":"170_CR59","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s0006-291x(02)00818-5","volume":"296","author":"S Blazer","year":"2002","unstructured":"Blazer, S. et al. High glucose-induced replicative senescence: point of no return and effect of telomerase. Biochem. Biophys. Res. Commun. 296, 93\u2013101, https:\/\/doi.org\/10.1016\/s0006-291x(02)00818-5 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"170_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/agm2.12106","volume":"3","author":"XJ Cui","year":"2020","unstructured":"Cui, X. J. et al. Adiponectin attenuates the premature senescence of vascular smooth muscle cells induced by high glucose through mTOR signaling pathway. Aging Med. 3, 178\u2013187, https:\/\/doi.org\/10.1002\/agm2.12106 (2020).","journal-title":"Aging Med."},{"key":"170_CR61","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1159\/000350090","volume":"31","author":"J Jin","year":"2013","unstructured":"Jin, J. & Zhang, T. Effects of glucose restriction on replicative senescence of human diploid fibroblasts IMR-90. Cell. Physiol. Biochem. 31, 718\u2013727, https:\/\/doi.org\/10.1159\/000350090 (2013).","journal-title":"Cell. Physiol. Biochem."},{"key":"170_CR62","doi-asserted-by":"publisher","unstructured":"Narasimhan, A., Flores, R. R., Robbins, P. D. & Niedernhofer, L. J. Role of cellular senescence in type II diabetes. Endocrinology 162 https:\/\/doi.org\/10.1210\/endocr\/bqab136 (2021).","DOI":"10.1210\/endocr\/bqab136"},{"key":"170_CR63","doi-asserted-by":"publisher","unstructured":"Shosha, E. et al. Mechanisms of diabetes-induced endothelial cell senescence: role of arginase 1. Int. J. Mol. Sci. 19 https:\/\/doi.org\/10.3390\/ijms19041215 (2018).","DOI":"10.3390\/ijms19041215"},{"key":"170_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.929118","volume":"13","author":"PM Bertelli","year":"2022","unstructured":"Bertelli, P. M. et al. Long term high glucose exposure induces premature senescence in retinal endothelial cells. Front. Physiol. 13, 929118, https:\/\/doi.org\/10.3389\/fphys.2022.929118 (2022).","journal-title":"Front. Physiol."},{"key":"170_CR65","doi-asserted-by":"publisher","first-page":"17018","DOI":"10.1073\/pnas.0607873103","volume":"103","author":"T Hayashi","year":"2006","unstructured":"Hayashi, T. et al. Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc. Natl. Acad. Sci. USA 103, 17018\u201317023, https:\/\/doi.org\/10.1073\/pnas.0607873103 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"170_CR66","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cellsig.2013.10.002","volume":"26","author":"J Liu","year":"2014","unstructured":"Liu, J. et al. Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling. Cell Signal. 26, 110\u2013121, https:\/\/doi.org\/10.1016\/j.cellsig.2013.10.002 (2014).","journal-title":"Cell Signal."},{"key":"170_CR67","doi-asserted-by":"publisher","first-page":"C621","DOI":"10.1152\/ajpcell.00096.2014","volume":"308","author":"J Liu","year":"2015","unstructured":"Liu, J. et al. Impact of ER stress-regulated ATF4\/p16 signaling on the premature senescence of renal tubular epithelial cells in diabetic nephropathy. Am. J. Physiol. Cell Physiol. 308, C621\u2013C630, https:\/\/doi.org\/10.1152\/ajpcell.00096.2014 (2015).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"170_CR68","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1194\/jlr.R066597","volume":"57","author":"AK Hauck","year":"2016","unstructured":"Hauck, A. K. & Bernlohr, D. A. Oxidative stress and lipotoxicity. J. Lipid Res. 57, 1976\u20131986, https:\/\/doi.org\/10.1194\/jlr.R066597 (2016).","journal-title":"J. Lipid Res."},{"key":"170_CR69","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1172\/JCI97949","volume":"128","author":"M Trayssac","year":"2018","unstructured":"Trayssac, M., Hannun, Y. A. & Obeid, L. M. Role of sphingolipids in senescence: implication in aging and age-related diseases. J. Clin. Investig. 128, 2702\u20132712, https:\/\/doi.org\/10.1172\/JCI97949 (2018).","journal-title":"J. Clin. Investig."},{"key":"170_CR70","doi-asserted-by":"publisher","first-page":"H571","DOI":"10.1152\/ajpheart.00038.2018","volume":"315","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Novel role of PKR in palmitate-induced Sirt1 inactivation and endothelial cell senescence. Am. J. Physiol. Heart Circ. Physiol. 315, H571\u2013H580, https:\/\/doi.org\/10.1152\/ajpheart.00038.2018 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"170_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45582-8","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Palmitic acid in type 2 diabetes mellitus promotes atherosclerotic plaque vulnerability via macrophage Dll4 signaling. Nat. Commun. 15, 1281, https:\/\/doi.org\/10.1038\/s41467-024-45582-8 (2024).","journal-title":"Nat. Commun."},{"key":"170_CR72","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1530\/JOE-16-0317","volume":"231","author":"X Xiong","year":"2016","unstructured":"Xiong, X. et al. SIRT6 protects against palmitate-induced pancreatic beta-cell dysfunction and apoptosis. J. Endocrinol. 231, 159\u2013165, https:\/\/doi.org\/10.1530\/JOE-16-0317 (2016).","journal-title":"J. Endocrinol."},{"key":"170_CR73","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","volume":"14","author":"J Yoshino","year":"2011","unstructured":"Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528\u2013536, https:\/\/doi.org\/10.1016\/j.cmet.2011.08.014 (2011).","journal-title":"Cell Metab."},{"key":"170_CR74","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/s42255-020-00305-3","volume":"2","author":"AJ Covarrubias","year":"2020","unstructured":"Covarrubias, A. J. et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nat. Metab. 2, 1265\u20131283, https:\/\/doi.org\/10.1038\/s42255-020-00305-3 (2020).","journal-title":"Nat. Metab."},{"key":"170_CR75","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","volume":"15","author":"C Canto","year":"2012","unstructured":"Canto, C. et al. The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 15, 838\u2013847, https:\/\/doi.org\/10.1016\/j.cmet.2012.04.022 (2012).","journal-title":"Cell Metab."},{"key":"170_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/srep26933","volume":"6","author":"SA Trammell","year":"2016","unstructured":"Trammell, S. A. et al. Nicotinamide riboside opposes type 2 diabetes and neuropathy in mice. Sci. Rep. 6, 26933, https:\/\/doi.org\/10.1038\/srep26933 (2016).","journal-title":"Sci. Rep."},{"key":"170_CR77","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","volume":"23","author":"J Camacho-Pereira","year":"2016","unstructured":"Camacho-Pereira, J. et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 23, 1127\u20131139, https:\/\/doi.org\/10.1016\/j.cmet.2016.05.006 (2016).","journal-title":"Cell Metab."},{"key":"170_CR78","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41392-021-00625-0","volume":"6","author":"L Gan","year":"2021","unstructured":"Gan, L. et al. CD38 deficiency alleviates Ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice. Signal Transduct. Target. Ther. 6, 223, https:\/\/doi.org\/10.1038\/s41392-021-00625-0 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"170_CR79","doi-asserted-by":"publisher","unstructured":"Wang, L. F. et al. CD38 deficiency alleviates diabetic cardiomyopathy by coordinately inhibiting pyroptosis and apoptosis. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms242116008 (2023).","DOI":"10.3390\/ijms242116008"},{"key":"170_CR80","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cmet.2018.03.016","volume":"27","author":"MG Tarrago","year":"2018","unstructured":"Tarrago, M. G. et al. A potent and specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD+ decline. Cell Metab. 27, 1081\u20131095 e1010, https:\/\/doi.org\/10.1016\/j.cmet.2018.03.016 (2018).","journal-title":"Cell Metab."},{"key":"170_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/npjamd.2016.17","volume":"2","author":"SI Imai","year":"2016","unstructured":"Imai, S. I. & Guarente, L. It takes two to tango: NAD+ and sirtuins in aging\/longevity control. NPJ Aging Mech. Dis. 2, 16017, https:\/\/doi.org\/10.1038\/npjamd.2016.17 (2016).","journal-title":"NPJ Aging Mech. Dis."},{"key":"170_CR82","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41569-022-00685-x","volume":"19","author":"MOJ Grootaert","year":"2022","unstructured":"Grootaert, M. O. J. & Bennett, M. R. Sirtuins in atherosclerosis: guardians of healthspan and therapeutic targets. Nat. Rev. Cardiol. 19, 668\u2013683, https:\/\/doi.org\/10.1038\/s41569-022-00685-x (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"170_CR83","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","volume":"24","author":"S Imai","year":"2014","unstructured":"Imai, S. & Guarente, L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 24, 464\u2013471, https:\/\/doi.org\/10.1016\/j.tcb.2014.04.002 (2014).","journal-title":"Trends Cell Biol."},{"key":"170_CR84","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/CIRCRESAHA.118.312498","volume":"123","author":"AE Kane","year":"2018","unstructured":"Kane, A. E. & Sinclair, D. A. Sirtuins and NAD+ in the development and treatment of metabolic and cardiovascular diseases. Circ. Res. 123, 868\u2013885, https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312498 (2018).","journal-title":"Circ. Res."},{"key":"170_CR85","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960\u2013976, https:\/\/doi.org\/10.1016\/j.cell.2017.02.004 (2017).","journal-title":"Cell"},{"key":"170_CR86","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","volume":"460","author":"DE Harrison","year":"2009","unstructured":"Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392\u2013395, https:\/\/doi.org\/10.1038\/nature08221 (2009).","journal-title":"Nature"},{"key":"170_CR87","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000484629","volume":"64","author":"T Weichhart","year":"2018","unstructured":"Weichhart, T. mTOR as regulator of lifespan, aging, and cellular senescence: a mini-review. Gerontology 64, 127\u2013134, https:\/\/doi.org\/10.1159\/000484629 (2018).","journal-title":"Gerontology"},{"key":"170_CR88","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.4161\/cc.8.12.8606","volume":"8","author":"ZN Demidenko","year":"2009","unstructured":"Demidenko, Z. N. et al. Rapamycin decelerates cellular senescence. Cell Cycle 8, 1888\u20131895, https:\/\/doi.org\/10.4161\/cc.8.12.8606 (2009).","journal-title":"Cell Cycle"},{"key":"170_CR89","doi-asserted-by":"publisher","first-page":"89ra58","DOI":"10.1126\/scitranslmed.3002346","volume":"3","author":"K Cao","year":"2011","unstructured":"Cao, K. et al. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci. Transl. Med. 3, 89ra58, https:\/\/doi.org\/10.1126\/scitranslmed.3002346 (2011).","journal-title":"Sci. Transl. Med."},{"key":"170_CR90","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/15548627.2016.1247143","volume":"13","author":"H Tai","year":"2017","unstructured":"Tai, H. et al. Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence. Autophagy 13, 99\u2013113, https:\/\/doi.org\/10.1080\/15548627.2016.1247143 (2017).","journal-title":"Autophagy"},{"key":"170_CR91","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.exger.2017.08.001","volume":"109","author":"JY Sung","year":"2018","unstructured":"Sung, J. Y., Lee, K. Y., Kim, J. R. & Choi, H. C. Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through decreased expressions of p53\/p21\/p16. Exp. Gerontol. 109, 51\u201358, https:\/\/doi.org\/10.1016\/j.exger.2017.08.001 (2018).","journal-title":"Exp. Gerontol."},{"key":"170_CR92","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ncb3195","volume":"17","author":"RM Laberge","year":"2015","unstructured":"Laberge, R. M. et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat. Cell Biol. 17, 1049\u20131061, https:\/\/doi.org\/10.1038\/ncb3195 (2015).","journal-title":"Nat. Cell Biol."},{"key":"170_CR93","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/ncb3225","volume":"17","author":"N Herranz","year":"2015","unstructured":"Herranz, N. et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat. Cell Biol. 17, 1205\u20131217, https:\/\/doi.org\/10.1038\/ncb3225 (2015).","journal-title":"Nat. Cell Biol."},{"key":"170_CR94","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/acel.12587","volume":"16","author":"R Wang","year":"2017","unstructured":"Wang, R. et al. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism. Aging Cell 16, 564\u2013574, https:\/\/doi.org\/10.1111\/acel.12587 (2017).","journal-title":"Aging Cell"},{"key":"170_CR95","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nature06322","volume":"450","author":"JT Cunningham","year":"2007","unstructured":"Cunningham, J. T. et al. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450, 736\u2013740, https:\/\/doi.org\/10.1038\/nature06322 (2007).","journal-title":"Nature"},{"key":"170_CR96","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","volume":"1","author":"Y Aman","year":"2021","unstructured":"Aman, Y. et al. Autophagy in healthy aging and disease. Nat Aging 1, 634\u2013650, https:\/\/doi.org\/10.1038\/s43587-021-00098-4 (2021).","journal-title":"Nat Aging"},{"key":"170_CR97","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1002\/1878-0261.13269","volume":"16","author":"LD Cassidy","year":"2022","unstructured":"Cassidy, L. D. & Narita, M. Autophagy at the intersection of aging, senescence, and cancer. Mol. Oncol. 16, 3259\u20133275, https:\/\/doi.org\/10.1002\/1878-0261.13269 (2022).","journal-title":"Mol. Oncol."},{"key":"170_CR98","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7687083","volume":"2018","author":"MOJ Grootaert","year":"2018","unstructured":"Grootaert, M. O. J., Roth, L., Schrijvers, D. M., De Meyer, G. R. Y. & Martinet, W. Defective autophagy in atherosclerosis: to die or to senesce? Oxid. Med. Cell. Longev. 2018, 7687083, https:\/\/doi.org\/10.1155\/2018\/7687083 (2018).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"170_CR99","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1101\/gad.519709","volume":"23","author":"AR Young","year":"2009","unstructured":"Young, A. R. et al. Autophagy mediates the mitotic senescence transition. Genes Dev. 23, 798\u2013803, https:\/\/doi.org\/10.1101\/gad.519709 (2009).","journal-title":"Genes Dev."},{"key":"170_CR100","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1126\/science.1205407","volume":"332","author":"M Narita","year":"2011","unstructured":"Narita, M. et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 332, 966\u2013970, https:\/\/doi.org\/10.1126\/science.1205407 (2011).","journal-title":"Science"},{"key":"170_CR101","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1093\/eurheartj\/ehz919","volume":"41","author":"SD Stojanovic","year":"2020","unstructured":"Stojanovic, S. D., Fiedler, J., Bauersachs, J., Thum, T. & Sedding, D. G. Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis. Eur. Heart J. 41, 2983\u20132996, https:\/\/doi.org\/10.1093\/eurheartj\/ehz919 (2020).","journal-title":"Eur. Heart J."},{"key":"170_CR102","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2991\/jegh.k.201217.001","volume":"11","author":"U Ralapanawa","year":"2021","unstructured":"Ralapanawa, U. & Sivakanesan, R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J. Epidemiol. Glob. Health 11, 169\u2013177, https:\/\/doi.org\/10.2991\/jegh.k.201217.001 (2021).","journal-title":"J. Epidemiol. Glob. Health"},{"key":"170_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94097-5","volume":"11","author":"S Honda","year":"2021","unstructured":"Honda, S. et al. Cellular senescence promotes endothelial activation through epigenetic alteration, and consequently accelerates atherosclerosis. Sci. Rep. 11, 14608, https:\/\/doi.org\/10.1038\/s41598-021-94097-5 (2021).","journal-title":"Sci. Rep."},{"key":"170_CR104","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/acel.12458","volume":"15","author":"CM Roos","year":"2016","unstructured":"Roos, C. M. et al. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice. Aging Cell 15, 973\u2013977, https:\/\/doi.org\/10.1111\/acel.12458 (2016).","journal-title":"Aging Cell"},{"key":"170_CR105","doi-asserted-by":"publisher","unstructured":"Hernandez-Silva, D. et al. Senescence-independent anti-inflammatory activity of the senolytic drugs dasatinib, navitoclax, and venetoclax in zebrafish models of chronic inflammation. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms231810468 (2022).","DOI":"10.3390\/ijms231810468"},{"key":"170_CR106","doi-asserted-by":"publisher","unstructured":"Karnewar, S., Karnewar, V., Shankman, L. S. & Owens, G. K. Treatment of advanced atherosclerotic mice with ABT-263 reduced indices of plaque stability and increased mortality. JCI Insight 9 https:\/\/doi.org\/10.1172\/jci.insight.173863 (2024).","DOI":"10.1172\/jci.insight.173863"},{"key":"170_CR107","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese, G. et al. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc. Res. 118, 3272\u20133287, https:\/\/doi.org\/10.1093\/cvr\/cvac013 (2023).","journal-title":"Cardiovasc. Res."},{"key":"170_CR108","doi-asserted-by":"publisher","unstructured":"Simmonds, S. J., Cuijpers, I., Heymans, S. & Jones, E. A. V. Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding. Cells 9 https:\/\/doi.org\/10.3390\/cells9010242 (2020).","DOI":"10.3390\/cells9010242"},{"key":"170_CR109","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s44161-022-00032-w","volume":"1","author":"GG Schiattarella","year":"2022","unstructured":"Schiattarella, G. G. et al. Immunometabolic mechanisms of heart failure with preserved ejection fraction. Nat. Cardiovasc. Res. 1, 211\u2013222, https:\/\/doi.org\/10.1038\/s44161-022-00032-w (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"170_CR110","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1002\/ehf2.13429","volume":"8","author":"L Gaziano","year":"2021","unstructured":"Gaziano, L. et al. Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction. ESC Heart Fail. 8, 4893\u20134903, https:\/\/doi.org\/10.1002\/ehf2.13429 (2021).","journal-title":"ESC Heart Fail."},{"key":"170_CR111","doi-asserted-by":"publisher","unstructured":"Gevaert, A. B. et al. Endothelial senescence contributes to heart failure with preserved ejection fraction in an aging mouse model. Circ. Heart Fail. 10 https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.116.003806 (2017).","DOI":"10.1161\/CIRCHEARTFAILURE.116.003806"},{"key":"170_CR112","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","volume":"6","author":"BM Leon","year":"2015","unstructured":"Leon, B. M. & Maddox, T. M. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J. Diabetes 6, 1246\u20131258, https:\/\/doi.org\/10.4239\/wjd.v6.i13.1246 (2015).","journal-title":"World J. Diabetes"},{"key":"170_CR113","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2337\/diacare.28.2.385","volume":"28","author":"AM McNeill","year":"2005","unstructured":"McNeill, A. M. et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28, 385\u2013390, https:\/\/doi.org\/10.2337\/diacare.28.2.385 (2005).","journal-title":"Diabetes Care"},{"key":"170_CR114","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00125-004-1605-2","volume":"48","author":"H Sone","year":"2005","unstructured":"Sone, H. & Kagawa, Y. Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48, 58\u201367, https:\/\/doi.org\/10.1007\/s00125-004-1605-2 (2005).","journal-title":"Diabetologia"},{"key":"170_CR115","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cmet.2019.05.006","volume":"30","author":"C Aguayo-Mazzucato","year":"2019","unstructured":"Aguayo-Mazzucato, C. et al. Acceleration of beta cell aging determines diabetes and senolysis improves disease outcomes. Cell Metab. 30, 129\u2013142 e124, https:\/\/doi.org\/10.1016\/j.cmet.2019.05.006 (2019).","journal-title":"Cell Metab."},{"key":"170_CR116","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12950","volume":"18","author":"AK Palmer","year":"2019","unstructured":"Palmer, A. K. et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell 18, e12950, https:\/\/doi.org\/10.1111\/acel.12950 (2019).","journal-title":"Aging Cell"},{"key":"170_CR117","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13767","volume":"22","author":"MT Islam","year":"2023","unstructured":"Islam, M. T. et al. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age. Aging Cell 22, e13767, https:\/\/doi.org\/10.1111\/acel.13767 (2023).","journal-title":"Aging Cell"},{"key":"170_CR118","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","volume":"47","author":"LJ Hickson","year":"2019","unstructured":"Hickson, L. J. et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine 47, 446\u2013456, https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.069 (2019).","journal-title":"EBioMedicine"},{"key":"170_CR119","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.acvd.2020.06.006","volume":"113","author":"S Battault","year":"2020","unstructured":"Battault, S. et al. Myocardial glucotoxicity: mechanisms and potential therapeutic targets. Arch. Cardiovasc. Dis. 113, 736\u2013748, https:\/\/doi.org\/10.1016\/j.acvd.2020.06.006 (2020).","journal-title":"Arch. Cardiovasc. Dis."},{"key":"170_CR120","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/cvr\/cvx018","volume":"113","author":"CR Chong","year":"2017","unstructured":"Chong, C. R., Clarke, K. & Levelt, E. Metabolic remodeling in diabetic cardiomyopathy. Cardiovasc. Res. 113, 422\u2013430, https:\/\/doi.org\/10.1093\/cvr\/cvx018 (2017).","journal-title":"Cardiovasc. Res."},{"key":"170_CR121","doi-asserted-by":"publisher","unstructured":"d\u2019Aiello, A. et al. Meta-inflammation and new anti-diabetic drugs: a new chance to knock down residual cardiovascular risk. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms24108643 (2023).","DOI":"10.3390\/ijms24108643"},{"key":"170_CR122","doi-asserted-by":"publisher","unstructured":"Anderson, R. et al. Length-independent telomere damage drives post-mitotic cardiomyocyte senescence. EMBO J. 38 https:\/\/doi.org\/10.15252\/embj.2018100492 (2019).","DOI":"10.15252\/embj.2018100492"},{"key":"170_CR123","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1161\/CIRCRESAHA.116.307505","volume":"118","author":"EJ Lesnefsky","year":"2016","unstructured":"Lesnefsky, E. J., Chen, Q. & Hoppel, C. L. Mitochondrial metabolism in aging heart. Circ. Res. 118, 1593\u20131611, https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.307505 (2016).","journal-title":"Circ. Res."},{"key":"170_CR124","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/01.RES.0000231289.63468.08","volume":"99","author":"M Rota","year":"2006","unstructured":"Rota, M. et al. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ. Res. 99, 42\u201352, https:\/\/doi.org\/10.1161\/01.RES.0000231289.63468.08 (2006).","journal-title":"Circ. Res."},{"key":"170_CR125","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.2337\/db21-0536","volume":"71","author":"F Marino","year":"2022","unstructured":"Marino, F. et al. Diabetes-induced cellular senescence and senescence-associated secretory phenotype impair cardiac regeneration and function independently of age. Diabetes 71, 1081\u20131098, https:\/\/doi.org\/10.2337\/db21-0536 (2022).","journal-title":"Diabetes"},{"key":"170_CR126","doi-asserted-by":"publisher","unstructured":"Rodgers, J. L. et al. Cardiovascular risks associated with gender and aging. J. Cardiovasc. Dev. Dis. 6 https:\/\/doi.org\/10.3390\/jcdd6020019 (2019).","DOI":"10.3390\/jcdd6020019"},{"key":"170_CR127","doi-asserted-by":"publisher","first-page":"H868","DOI":"10.1152\/ajpheart.00931.2009","volume":"299","author":"OM Hyyti","year":"2010","unstructured":"Hyyti, O. M., Ledee, D., Ning, X. H., Ge, M. & Portman, M. A. Aging impairs myocardial fatty acid and ketone oxidation and modifies cardiac functional and metabolic responses to insulin in mice. Am. J. Physiol. Heart Circ. Physiol. 299, H868\u2013875, https:\/\/doi.org\/10.1152\/ajpheart.00931.2009 (2010).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"170_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166642","volume":"1869","author":"JM Osorio","year":"2023","unstructured":"Osorio, J. M. et al. Senescent cardiac fibroblasts: a key role in cardiac fibrosis. Biochim. Biophys. Acta Mol. Basis Dis. 1869, 166642, https:\/\/doi.org\/10.1016\/j.bbadis.2023.166642 (2023).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"170_CR129","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/acel.12344","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu, Y. et al. The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14, 644\u2013658, https:\/\/doi.org\/10.1111\/acel.12344 (2015).","journal-title":"Aging Cell"},{"key":"170_CR130","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12945","volume":"18","author":"A Walaszczyk","year":"2019","unstructured":"Walaszczyk, A. et al. Pharmacological clearance of senescent cells improves survival and recovery in aged mice following acute myocardial infarction. Aging Cell 18, e12945, https:\/\/doi.org\/10.1111\/acel.12945 (2019).","journal-title":"Aging Cell"},{"key":"170_CR131","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12931","volume":"18","author":"FC Lewis-McDougall","year":"2019","unstructured":"Lewis-McDougall, F. C. et al. Aged-senescent cells contribute to impaired heart regeneration. Aging Cell 18, e12931, https:\/\/doi.org\/10.1111\/acel.12931 (2019).","journal-title":"Aging Cell"},{"key":"170_CR132","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/s41591-022-01923-y","volume":"28","author":"S Chaib","year":"2022","unstructured":"Chaib, S., Tchkonia, T. & Kirkland, J. L. Cellular senescence and senolytics: the path to the clinic. Nat. Med. 28, 1556\u20131568, https:\/\/doi.org\/10.1038\/s41591-022-01923-y (2022).","journal-title":"Nat. Med."},{"key":"170_CR133","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14060","volume":"23","author":"SA Mahoney","year":"2024","unstructured":"Mahoney, S. A. et al. Intermittent supplementation with fisetin improves arterial function in old mice by decreasing cellular senescence. Aging Cell 23, e14060, https:\/\/doi.org\/10.1111\/acel.14060 (2024).","journal-title":"Aging Cell"},{"key":"170_CR134","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00280-014-2530-9","volume":"74","author":"A Kaefer","year":"2014","unstructured":"Kaefer, A. et al. Mechanism-based pharmacokinetic\/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia. Cancer Chemother. Pharmacol. 74, 593\u2013602, https:\/\/doi.org\/10.1007\/s00280-014-2530-9 (2014).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"170_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15838-0","volume":"11","author":"Y He","year":"2020","unstructured":"He, Y. et al. Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity. Nat. Commun. 11, 1996, https:\/\/doi.org\/10.1038\/s41467-020-15838-0 (2020).","journal-title":"Nat. Commun."},{"key":"170_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.741542","volume":"8","author":"O Dagher","year":"2021","unstructured":"Dagher, O. et al. Design of a randomized placebo-controlled trial to evaluate the anti-inflammatory and senolytic effects of quercetin in patients undergoing coronary artery bypass graft surgery. Front. Cardiovasc. Med. 8, 741542, https:\/\/doi.org\/10.3389\/fcvm.2021.741542 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"170_CR137","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2009.e4","volume":"1","author":"Z Xu","year":"2009","unstructured":"Xu, Z., Cang, S., Yang, T. & Liu, D. Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy. Hematol. Rev. 1, e4, https:\/\/doi.org\/10.4081\/hr.2009.e4 (2009).","journal-title":"Hematol. Rev."},{"key":"170_CR138","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1002\/cncr.24432","volume":"115","author":"A Quintas-Cardama","year":"2009","unstructured":"Quintas-Cardama, A. et al. Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure. Cancer 115, 3935\u20133943, https:\/\/doi.org\/10.1002\/cncr.24432 (2009).","journal-title":"Cancer"},{"key":"170_CR139","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nm.4385","volume":"23","author":"JN Farr","year":"2017","unstructured":"Farr, J. N. et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med. 23, 1072\u20131079, https:\/\/doi.org\/10.1038\/nm.4385 (2017).","journal-title":"Nat. Med."},{"key":"170_CR140","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s43587-024-00597-0","volume":"4","author":"R Wu","year":"2024","unstructured":"Wu, R., Sun, F., Zhang, W., Ren, J. & Liu, G. H. Targeting aging and age-related diseases with vaccines. Nat. Aging 4, 464\u2013482, https:\/\/doi.org\/10.1038\/s43587-024-00597-0 (2024).","journal-title":"Nat. Aging"},{"key":"170_CR141","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/febs.16350","volume":"290","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Pitcher, L. E., Prahalad, V., Niedernhofer, L. J. & Robbins, P. D. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. FEBS J. 290, 1362\u20131383, https:\/\/doi.org\/10.1111\/febs.16350 (2023).","journal-title":"FEBS J."},{"key":"170_CR142","doi-asserted-by":"publisher","unstructured":"Bitto, A. et al. Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice. Elife 5 https:\/\/doi.org\/10.7554\/eLife.16351 (2016).","DOI":"10.7554\/eLife.16351"},{"key":"170_CR143","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1172\/JCI67674","volume":"123","author":"F Neff","year":"2013","unstructured":"Neff, F. et al. Rapamycin extends murine lifespan but has limited effects on aging. J. Clin. Investig. 123, 3272\u20133291, https:\/\/doi.org\/10.1172\/JCI67674 (2013).","journal-title":"J. Clin. Investig."},{"key":"170_CR144","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.117.031735","volume":"137","author":"G Rena","year":"2018","unstructured":"Rena, G. & Lang, C. C. Repurposing metformin for cardiovascular disease. Circulation 137, 422\u2013424, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.031735 (2018).","journal-title":"Circulation"},{"key":"170_CR145","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","volume":"32","author":"AS Kulkarni","year":"2020","unstructured":"Kulkarni, A. S., Gubbi, S. & Barzilai, N. Benefits of metformin in attenuating the hallmarks of aging. Cell Metab. 32, 15\u201330, https:\/\/doi.org\/10.1016\/j.cmet.2020.04.001 (2020).","journal-title":"Cell Metab."},{"key":"170_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2023.1170434","volume":"4","author":"IY Abdelgawad","year":"2023","unstructured":"Abdelgawad, I. Y., Agostinucci, K., Sadaf, B., Grant, M. K. O. & Zordoky, B. N. Metformin mitigates SASP secretion and LPS-triggered hyper-inflammation in Doxorubicin-induced senescent endothelial cells. Front. Aging 4, 1170434, https:\/\/doi.org\/10.3389\/fragi.2023.1170434 (2023).","journal-title":"Front. Aging"},{"key":"170_CR147","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/acel.12075","volume":"12","author":"O Moiseeva","year":"2013","unstructured":"Moiseeva, O. et al. Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK\/NF-kappaB activation. Aging Cell 12, 489\u2013498, https:\/\/doi.org\/10.1111\/acel.12075 (2013).","journal-title":"Aging Cell"},{"key":"170_CR148","doi-asserted-by":"publisher","unstructured":"Le Pelletier, L. et al. Metformin alleviates stress-induced cellular senescence of aging human adipose stromal cells and the ensuing adipocyte dysfunction. Elife 10 https:\/\/doi.org\/10.7554\/eLife.62635 (2021).","DOI":"10.7554\/eLife.62635"},{"key":"170_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3192","volume":"4","author":"A Martin-Montalvo","year":"2013","unstructured":"Martin-Montalvo, A. et al. Metformin improves healthspan and lifespan in mice. Nat. Commun. 4, 2192, https:\/\/doi.org\/10.1038\/ncomms3192 (2013).","journal-title":"Nat. Commun."},{"key":"170_CR150","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/bjp.2008.272","volume":"155","author":"L Xia","year":"2008","unstructured":"Xia, L. et al. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br. J. Pharmacol. 155, 387\u2013394, https:\/\/doi.org\/10.1038\/bjp.2008.272 (2008).","journal-title":"Br. J. Pharmacol."},{"key":"170_CR151","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/gerona\/glr228","volume":"67","author":"A Csiszar","year":"2012","unstructured":"Csiszar, A. et al. Age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate Macaca mulatta: reversal by resveratrol treatment. J. Gerontol. A Biol. Sci. Med. Sci. 67, 811\u2013820, https:\/\/doi.org\/10.1093\/gerona\/glr228 (2012).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"170_CR152","doi-asserted-by":"publisher","first-page":"970","DOI":"10.5551\/jat.4333","volume":"17","author":"CL Kao","year":"2010","unstructured":"Kao, C. L. et al. Resveratrol protects human endothelium from H2O2-induced oxidative stress and senescence via SirT1 activation. J. Atheroscler. Thromb. 17, 970\u2013979, https:\/\/doi.org\/10.5551\/jat.4333 (2010).","journal-title":"J. Atheroscler. Thromb."},{"key":"170_CR153","doi-asserted-by":"publisher","first-page":"H13","DOI":"10.1152\/ajpheart.00368.2009","volume":"297","author":"A Csiszar","year":"2009","unstructured":"Csiszar, A. et al. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 297, H13\u201320, https:\/\/doi.org\/10.1152\/ajpheart.00368.2009 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"170_CR154","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2147\/DDDT.S179894","volume":"13","author":"L Du","year":"2019","unstructured":"Du, L., Chen, E., Wu, T., Ruan, Y. & Wu, S. Resveratrol attenuates hydrogen peroxide-induced aging through upregulation of autophagy in human umbilical vein endothelial cells. Drug Des. Dev. Ther. 13, 747\u2013755, https:\/\/doi.org\/10.2147\/DDDT.S179894 (2019).","journal-title":"Drug Des. Dev. Ther."},{"key":"170_CR155","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.2174\/0929867323666161024151233","volume":"23","author":"K Pallauf","year":"2016","unstructured":"Pallauf, K., Rimbach, G., Rupp, P. M., Chin, D. & Wolf, I. M. Resveratrol and lifespan in model organisms. Curr. Med. Chem. 23, 4639\u20134680, https:\/\/doi.org\/10.2174\/0929867323666161024151233 (2016).","journal-title":"Curr. Med. Chem."},{"key":"170_CR156","doi-asserted-by":"publisher","first-page":"E6301","DOI":"10.1073\/pnas.1515386112","volume":"112","author":"M Xu","year":"2015","unstructured":"Xu, M. et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc. Natl. Acad. Sci. USA 112, E6301\u2013E6310, https:\/\/doi.org\/10.1073\/pnas.1515386112 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"170_CR157","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1161\/ATVBAHA.110.210500","volume":"30","author":"H Ota","year":"2010","unstructured":"Ota, H. et al. Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arterioscler. Thromb. Vasc. Biol. 30, 2205\u20132211, https:\/\/doi.org\/10.1161\/ATVBAHA.110.210500 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"170_CR158","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1096\/fj.13-232066","volume":"27","author":"V Boccardi","year":"2013","unstructured":"Boccardi, V. et al. A new pleiotropic effect of statins in elderly: modulation of telomerase activity. FASEB J. 27, 3879\u20133885, https:\/\/doi.org\/10.1096\/fj.13-232066 (2013).","journal-title":"FASEB J."},{"key":"170_CR159","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCRESAHA.108.182899","volume":"103","author":"M Mahmoudi","year":"2008","unstructured":"Mahmoudi, M. et al. Statins use a novel Nijmegen breakage syndrome-1-dependent pathway to accelerate DNA repair in vascular smooth muscle cells. Circ. Res. 103, 717\u2013725, https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.182899 (2008).","journal-title":"Circ. Res."},{"key":"170_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2021.111432","volume":"194","author":"E Roupakia","year":"2021","unstructured":"Roupakia, E., Markopoulos, G. S. & Kolettas, E. Genes and pathways involved in senescence bypass identified by functional genetic screens. Mech. Ageing Dev. 194, 111432, https:\/\/doi.org\/10.1016\/j.mad.2021.111432 (2021).","journal-title":"Mech. Ageing Dev."},{"key":"170_CR161","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/carcin\/bgaa071","volume":"41","author":"J Beck","year":"2020","unstructured":"Beck, J., Turnquist, C., Horikawa, I. & Harris, C. Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms. Carcinogenesis 41, 1017\u20131029, https:\/\/doi.org\/10.1093\/carcin\/bgaa071 (2020).","journal-title":"Carcinogenesis"},{"key":"170_CR162","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1172\/JCI70355","volume":"123","author":"AM Mondal","year":"2013","unstructured":"Mondal, A. M. et al. p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes. J. Clin. Investig. 123, 5247\u20135257, https:\/\/doi.org\/10.1172\/JCI70355 (2013).","journal-title":"J. Clin. Investig."},{"key":"170_CR163","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.cell.2016.11.052","volume":"167","author":"A Ocampo","year":"2016","unstructured":"Ocampo, A. et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, 1719\u20131733 e1712, https:\/\/doi.org\/10.1016\/j.cell.2016.11.052 (2016).","journal-title":"Cell"},{"key":"170_CR164","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s43587-022-00183-2","volume":"2","author":"KC Browder","year":"2022","unstructured":"Browder, K. C. et al. In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice. Nat. Aging 2, 243\u2013253, https:\/\/doi.org\/10.1038\/s43587-022-00183-2 (2022).","journal-title":"Nat. Aging"},{"key":"170_CR165","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s43587-021-00151-2","volume":"1","author":"M Suda","year":"2021","unstructured":"Suda, M. et al. Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice. Nat. Aging 1, 1117\u20131126, https:\/\/doi.org\/10.1038\/s43587-021-00151-2 (2021).","journal-title":"Nat. Aging"},{"key":"170_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16347-w","volume":"11","author":"S Yoshida","year":"2020","unstructured":"Yoshida, S. et al. The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice. Nat. Commun. 11, 2482, https:\/\/doi.org\/10.1038\/s41467-020-16347-w (2020).","journal-title":"Nat. Commun."},{"key":"170_CR167","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor, C. et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature 583, 127\u2013132, https:\/\/doi.org\/10.1038\/s41586-020-2403-9 (2020).","journal-title":"Nature"},{"key":"170_CR168","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s43587-023-00560-5","volume":"4","author":"C Amor","year":"2024","unstructured":"Amor, C. et al. Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction. Nat. Aging 4, 336\u2013349, https:\/\/doi.org\/10.1038\/s43587-023-00560-5 (2024).","journal-title":"Nat. Aging"},{"key":"170_CR169","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1101\/gad.302570.117","volume":"31","author":"KM Kim","year":"2017","unstructured":"Kim, K. M. et al. Identification of senescent cell surface targetable protein DPP4. Genes Dev. 31, 1529\u20131534, https:\/\/doi.org\/10.1101\/gad.302570.117 (2017).","journal-title":"Genes Dev."},{"key":"170_CR170","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/CIRCULATIONAHA.122.058794","volume":"147","author":"E Born","year":"2023","unstructured":"Born, E. et al. Eliminating senescent cells can promote pulmonary hypertension development and progression. Circulation 147, 650\u2013666, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.058794 (2023).","journal-title":"Circulation"},{"key":"170_CR171","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2020.05.002","volume":"32","author":"L Grosse","year":"2020","unstructured":"Grosse, L. et al. Defined p16High senescent cell types are indispensable for mouse healthspan. Cell Metab. 32, 87\u201399 e86, https:\/\/doi.org\/10.1016\/j.cmet.2020.05.002 (2020).","journal-title":"Cell Metab."},{"key":"170_CR172","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2020.03.017","volume":"145","author":"CE Gustafson","year":"2020","unstructured":"Gustafson, C. E., Kim, C., Weyand, C. M. & Goronzy, J. J. Influence of immune aging on vaccine responses. J. Allergy Clin. Immunol. 145, 1309\u20131321, https:\/\/doi.org\/10.1016\/j.jaci.2020.03.017 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"170_CR173","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000492573","volume":"65","author":"JM Castellano","year":"2019","unstructured":"Castellano, J. M. Blood-based therapies to combat aging. Gerontology 65, 84\u201389, https:\/\/doi.org\/10.1159\/000492573 (2019).","journal-title":"Gerontology"},{"key":"170_CR174","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1007\/s11357-022-00645-w","volume":"44","author":"D Kim","year":"2022","unstructured":"Kim, D. et al. Old plasma dilution reduces human biological age: a clinical study. Geroscience 44, 2701\u20132720, https:\/\/doi.org\/10.1007\/s11357-022-00645-w (2022).","journal-title":"Geroscience"}],"container-title":["npj Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41514-024-00170-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-024-00170-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-024-00170-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T19:02:56Z","timestamp":1729537376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41514-024-00170-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":174,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["170"],"URL":"https:\/\/doi.org\/10.1038\/s41514-024-00170-4","relation":{},"ISSN":["2731-6068"],"issn-type":[{"value":"2731-6068","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"22 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}